PROCEPT BioRobotics Corp. (PRCT)
30.74
-0.72
(-2.30%)
USD |
NASDAQ |
Jan 02, 16:00
31.36
+0.62
(+2.03%)
After-Hours: 17:57
PROCEPT BioRobotics Research and Development Expense (TTM): 64.08M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics, Inc. | 61.22M |
| Xtant Medical Holdings, Inc. | 2.165M |
| VolitionRX Ltd. | 9.144M |
| Catheter Precision, Inc. | 0.625M |
| Picard Medical, Inc. | 3.291M |